APA (7th ed.) Citation

Gambaro, K., Marques, M., McNamara, S., Couetoux du Tertre, M., Hoffert, C., Srivastava, A., . . . Kavan, P. (2024). A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy. International Journal of Molecular Sciences, 25(1), 43. https://doi.org/10.3390/ijms25010043

Chicago Style (17th ed.) Citation

Gambaro, Karen, et al. "A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy." International Journal of Molecular Sciences 25, no. 1 (2024): 43. https://doi.org/10.3390/ijms25010043.

MLA (9th ed.) Citation

Gambaro, Karen, et al. "A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy." International Journal of Molecular Sciences, vol. 25, no. 1, 2024, p. 43, https://doi.org/10.3390/ijms25010043.